3B5 Relative Valuation - IGEA Pharma NV

Watchlist Manager

Watchlist

Price: 16.791 EUR -3.07% Market Closed

Market Cap: €10.6m

	IGEA Pharma NV F:3B5	NL
P	Pennant Group Inc NASDAQ:PNTG	US
	Musti Group Oyj F:49U	FI
	Shakti Pumps India Ltd NSE:SHAKTIPUMP	IN
	Meghmani Organics Ltd NSE:MOL	IN
T	Tekna Holding ASA OSE:TEKNA	NO

Multiples-Based Value

3B5 price has not been updated for more than 5 years. This may indicate that the stock has been delisted.

3B5 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the multiples-based value of 3B5.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

3B5 Multiples-Based Value

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
NL	IGEA Pharma NV F:3B5	505.5k EUR	0	0.4	-3	-3
US	Abbott Laboratories NYSE:ABT	174.2B USD	3.9	26.8	15.4	21.1
US	Intuitive Surgical Inc NASDAQ:ISRG	160B USD	16.2	57.1	43.2	53.1
US	Stryker Corp NYSE:SYK	129.7B USD	5.3	40.9	20.8	25.2
IE	Medtronic PLC NYSE:MDT	112.9B USD	3.2	24.5	13.5	19.7
US	Boston Scientific Corp NYSE:BSX	91.6B USD	4.7	32.3	19.2	25.7
DE	Siemens Healthineers AG XETRA:SHL	42.6B EUR	1.8	20.2	11.3	15.9
US	Edwards Lifesciences Corp NYSE:EW	45.4B USD	7.5	42.3	23.1	25.3
US	IDEXX Laboratories Inc NASDAQ:IDXX	44.9B USD	10.6	43.2	30.6	33.9
US	Becton Dickinson and Co NYSE:BDX	44.3B USD	2	25.2	10	16.9
US	GE Healthcare Technologies Inc NASDAQ:GEHC	33.6B USD	1.6	16.1	11.6	14

			Revenue Growth	P/S to Growth
NL	IGEA Pharma NV F:3B5	Average P/S: 5.7 Not Available	N/A	N/A
US	Abbott Laboratories NYSE:ABT	3.9	8%	0.5
US	Intuitive Surgical Inc NASDAQ:ISRG	16.2	15%	1.1
US	Stryker Corp NYSE:SYK	5.3	9%	0.6
IE	Medtronic PLC NYSE:MDT	3.2	7%	0.5
US	Boston Scientific Corp NYSE:BSX	4.7	11%	0.4
DE	Siemens Healthineers AG XETRA:SHL	1.8	5%	0.4
US	Edwards Lifesciences Corp NYSE:EW	7.5	11%	0.7
US	IDEXX Laboratories Inc NASDAQ:IDXX	10.6	10%	1.1
US	Becton Dickinson and Co NYSE:BDX	2	-2%	N/A
US	GE Healthcare Technologies Inc NASDAQ:GEHC	1.6	5%	0.3

			Earnings Growth	PEG
NL	IGEA Pharma NV F:3B5	Average P/E: 29.9 0.4	N/A	N/A
US	Abbott Laboratories NYSE:ABT	26.8	23%	1.2
US	Intuitive Surgical Inc NASDAQ:ISRG	57.1	19%	3
US	Stryker Corp NYSE:SYK	40.9	30%	1.4
IE	Medtronic PLC NYSE:MDT	24.5	22%	1.1
US	Boston Scientific Corp NYSE:BSX	32.3	32%	1
DE	Siemens Healthineers AG XETRA:SHL	20.2	16%	1.3
US	Edwards Lifesciences Corp NYSE:EW	42.3	27%	1.6
US	IDEXX Laboratories Inc NASDAQ:IDXX	43.2	13%	3.3
US	Becton Dickinson and Co NYSE:BDX	25.2	35%	0.7
US	GE Healthcare Technologies Inc NASDAQ:GEHC	16.1	11%	1.5

			EBITDA Growth	EV/EBITDA to Growth
NL	IGEA Pharma NV F:3B5	Average EV/EBITDA: 19.9 Negative Multiple: -3	N/A	N/A
US	Abbott Laboratories NYSE:ABT	15.4	11%	1.4
US	Intuitive Surgical Inc NASDAQ:ISRG	43.2	23%	1.9
US	Stryker Corp NYSE:SYK	20.8	12%	1.7
IE	Medtronic PLC NYSE:MDT	13.5	8%	1.7
US	Boston Scientific Corp NYSE:BSX	19.2	18%	1.1
DE	Siemens Healthineers AG XETRA:SHL	11.3	10%	1.1
US	Edwards Lifesciences Corp NYSE:EW	23.1	14%	1.7
US	IDEXX Laboratories Inc NASDAQ:IDXX	30.6	11%	2.8
US	Becton Dickinson and Co NYSE:BDX	10	1%	10
US	GE Healthcare Technologies Inc NASDAQ:GEHC	11.6	12%	1

			EBIT Growth	EV/EBIT to Growth
NL	IGEA Pharma NV F:3B5	Average EV/EBIT: 25.1 Negative Multiple: -3	N/A	N/A
US	Abbott Laboratories NYSE:ABT	21.1	18%	1.2
US	Intuitive Surgical Inc NASDAQ:ISRG	53.1	25%	2.1
US	Stryker Corp NYSE:SYK	25.2	16%	1.6
IE	Medtronic PLC NYSE:MDT	19.7	17%	1.2
US	Boston Scientific Corp NYSE:BSX	25.7	25%	1
DE	Siemens Healthineers AG XETRA:SHL	15.9	15%	1.1
US	Edwards Lifesciences Corp NYSE:EW	25.3	15%	1.7
US	IDEXX Laboratories Inc NASDAQ:IDXX	33.9	12%	2.8
US	Becton Dickinson and Co NYSE:BDX	16.9	15%	1.1
US	GE Healthcare Technologies Inc NASDAQ:GEHC	14	14%	1

IGEA Pharma NV
F:3B5

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

3B5 Competitors Multiples
IGEA Pharma NV Competitors

See Also

Company

Help

Tools

Stocks

IGEA Pharma NV F:3B5

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

3B5 Competitors Multiples IGEA Pharma NV Competitors

See Also

Company

Help

Tools

Stocks

IGEA Pharma NV
F:3B5

3B5 Competitors Multiples
IGEA Pharma NV Competitors